SHW
53
-2
MDLZ
22
-16
XOM
50
-3
HBAN
85
-2
PRU
77
-2
CL
59
3
AMT
37
-2
PM
58
4
CAT
70
-9
BLK
61
-5
RL
82
2
BMY
74
5
C
79
-2
APH
45
-10
FSLR
55
-11
HRB
41
3
EXPD
37
-5
AN
52
-13
MAC
68
-2
EMN
62
-3
SHW
53
-2
MDLZ
22
-16
XOM
50
-3
HBAN
85
-2
PRU
77
-2
CL
59
3
AMT
37
-2
PM
58
4
CAT
70
-9
BLK
61
-5
RL
82
2
BMY
74
5
C
79
-2
APH
45
-10
FSLR
55
-11
HRB
41
3
EXPD
37
-5
AN
52
-13
MAC
68
-2
EMN
62
-3
Financhill
Back

BNY Mellon Ultra Short Income ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
28

BKUI
BNY Mellon Ultra Short Income ETF

Last Price:
$49.83
Seasonality Move:
0.14%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$112.53
Seasonality Move:
-9.01%
Sell
28
BNY Mellon Ultra Short Income ETF (BKUI) is a Sell

Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?

  • The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.83. The Score for BKUI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BKUI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BKUI Stock Price Chart

What is BNY Mellon Ultra Short Income ETF's stock price today?

  • The BNY Mellon Ultra Short Income ETF share price today is $49.83
    The current trend is relatively stagnant and BKUI is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

BKUI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50 Sell
Chaikin Money Flow: 6770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.79 - 49.87) Sell
Bollinger Bands (100): (49.78 - 49.9) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

BKUI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.8 Buy
20-day SMA: 49.83 Sell
50-day SMA: 49.84 Sell
200-day SMA: 49.79 Buy
8-day EMA: 49.81 Buy
20-day EMA: 49.83 Buy
50-day EMA: 49.84 Sell
200-day EMA: 49.79 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

BNY Mellon Ultra Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):